Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods
Antonio Curcio, Roberta Rocca, Stefano Alcaro, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 620-620
Open Access | Times Cited: 14

Showing 14 citing articles:

A promising future for breast cancer therapy with hydroxamic acid-based histone deacetylase inhibitors
Tanima Das, Sunandita Bhar, Diya Ghosh, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108169-108169
Closed Access
Repurposing Linezolid in Conjunction with Histone Deacetylase Inhibitor Access in the Realm of Glioblastoma Therapies
I‐Chung Chen, Hong-Yi Lin, Zhengyang Liu, et al.
Journal of Medicinal Chemistry (2025)
Open Access
Enhancing HDAC Inhibitor Screening: Addressing Zinc Parameterization and Ligand Protonation in Docking Studies
Rocco Buccheri, Alessandro Coco, Lorella Pasquinucci, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 850-850
Open Access
New indolin-2-ones, possessing sunitinib scaffold as HDAC inhibitors and anti-cancer agents with potential VEGFR inhibition activity; design, synthesis and biological evaluation
Mozhdeh Yousefian, Maryam Hashemi, Vahid Eskandarpour, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108231-108231
Closed Access
Epigenetic marvels: exploring the landscape of colorectal cancer treatment through cutting-edge epigenetic-based drug strategies
Azar Tahghighi, Effat Seyedhashemi, Javad Mohammadi, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
Computationally Guided Design, Synthesis, and Evaluation of Novel Non-Hydroxamic Histone Deacetylase Inhibitors, Based on N-Trifluoroacetamide as a Zinc-Binding Group, Against Breast Cancer
Gerardo Morales-Herrejón, J. Benjamín García‐Vázquez, Cynthia Fernández–Pomares, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 351-351
Open Access
Discovery of novel selective HDAC6 inhibitors via a scaffold hopping approach for the treatment of idiopathic pulmonary fibrosis (IPF) in vitro and in vivo
Jishun Quan, Ma Chao, Xianchen Zhao, et al.
Bioorganic Chemistry (2025) Vol. 159, pp. 108360-108360
Closed Access
Anticancer efficacy of Spiruchostatin A: current insights into histone deacetylase inhibition and oncologic applications
S.M. Ibrahim, Muhammad Umer Khan, Iqra Khurram, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Synthetic Approaches and Clinical Applications of Representative HDAC Inhibitors for Cancer Therapy: A Review
Zhiyi Lv, Tianyi Ji, Jie Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117185-117185
Closed Access | Times Cited: 2
Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancer
Bidyadhar Sethy, Richa Upadhyay, Iin Narwanti, et al.
APOPTOSIS (2024) Vol. 29, Iss. 11-12, pp. 2047-2073
Open Access | Times Cited: 1
Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancer
Bidyadhar Sethy, Richa Upadhyay, Iin Narwanti, et al.
Research Square (Research Square) (2024)
Open Access
Correction: Curcio et al. The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods. Pharmaceuticals 2024, 17, 620
Antonio Curcio, Roberta Rocca, Stefano Alcaro, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1520-1520
Open Access
Design, synthesis and antitumor activity evaluation of benzimidazole derivatives with potent HDAC inhibitory activity
Jiantao Ping, Hongrui Chu, Yisheng Zhao, et al.
Medicinal Chemistry Research (2024)
Closed Access
Multiple machine learning algorithms, validation of external clinical cohort and assessments of model gain effects will better serve cancer research on bioinformatic models
Fangshi Xu, Zongyu Li, Hao Guan, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access
Page 1

Scroll to top